The present invention provides compounds of the formula (I); which are activators of glucokinase activity and, thus, may be employed as therapeutic agents for the treatment of glucokinase mediated conditions. Accordingly, the compounds of formula (I) may be employed for the prevention and the treatment of impaired glucose tolerance, type 2 diabetes and obesity.
-
Page/Page column 45-46
(2008/06/13)
More Articles about upstream products of 934266-81-6
Get Best Price for934266-81-64-{4-[1-(5-bromo-thiazolo[5,4-b]pyridin-2-ylcarbamoyl)2-cyclopentyl-ethyl]benzenesulfonyl}-piperazine-1-carboxylic acid tert-butyl ester